维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="SAROSDY MF"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Improved detection of recurrent bladder can-cer using the Bard BTA stat Test显示文摘	Sarosdy MF Hudson MA Ellis WJ	1997	Urology1997，50，3：	1
2	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
3	Comparison of guserelin and Leuprolide in Combined androgen blockage therapy显示文摘	Sarosdy MF Schellhammer PF Sharifi R	1998	Urology1998，52，1：	1
4	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
5	Results of a multicenter trial using the BTA-test to monitor for and diagnose recurrent bladder cancer显示文摘	Sarosdy MF De-Vere-White RW Soloway MS	1995	J Urol1995，154，2：	1
6	Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer 显示文摘	Sarosdy MF White RW Soloway MS	1995	J Urol1995，154，21：	1
7	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria 显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
8	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
9	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
10	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
11	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
12	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Michael F Sarosdy MF ScheUhammer P	2002	J Urol2002，168，5：	1
13	Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，5：	1
14	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
15	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria 显示文摘	SAROSDY MF KAHN PR ZIFFER MD	2006	J Urol2006，176，1：	1
16	Bropirimine immunotherapy of upper urinary tract carcinoma in situ 显示文摘	Pisters LL Carroll PR	1996	Urology1996，48，1：	1
17	Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guerin 显示文摘	Sarosdy MF Manyak MJ Sagalowsky AI	1998	Urology1998，51，2：	1
18	Clinical evaluation of a multi target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘	Sarosdy MF Schellhammer P Bokinsky G	2002	J Urol2002，168，19：	1
19	Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria显示文摘	Sarosdy MF Kahn PR Ziffer MD	2006	J Urol2006，176，1：	1
20	Results of a multicenter trial u- sing the BTA test to monitor for and diagnose recurrent bladder cancer 显示文摘	Sarosdy MF deVere White RW Soloway MS	1995	J Urol1995，154，21：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示